- Poster presentation
- Open Access
Clinical, biochemical, and genetic analysis of two Korean patients with Trichorhinophalangeal syndrome type I and growth hormone deficiency
International Journal of Pediatric Endocrinology volume 2013, Article number: P59 (2013)
Tricho-rhino-phalangeal syndrome type I (TRPSI) is a rare autosomal dominant hereditary disorder characterized by sparse hair, bulbous nose, long philtrum, thin upper lip, and skeletal abnormalities including cone-shaped epiphyses, shortening of the phalanges, and short stature. TRPSI is caused by mutations in the TRPS1 gene. Herein, we report two Korean cases of TRPSI. Although both patients (a 17-year-old-female and a 14-year-old male) had typical clinical findings, Patient 1 had an additional growth hormone (GH) deficiency. Treatment with recombinant human growth hormone (rhGH) 0.7 IU/kg/week led to an increase in growth velocity. Over 10 years of GH therapy, the mean growth velocity was 5.7±0.9 cm/year. While patient 2 showed a low response after the GH stimulation test, the patient had a poor response with rhGH therapy and GH therapy was discontinued after 6 months.
For the genetic analysis of the TRPS1 gene, two mutations were found. Patient 1 had a heterozygous mutation c.2520dupT (p.Arg841LysfsX3) which had not been previously reported. Patient 2 had a known nonsense mutation c.1630C>T (p.Arg544X). In summary, we were the first to report Korean patients with mutation of TRPS1.
About this article
Cite this article
Sohn, Y.B., Ki, CS., Park, S.W. et al. Clinical, biochemical, and genetic analysis of two Korean patients with Trichorhinophalangeal syndrome type I and growth hormone deficiency. Int J Pediatr Endocrinol 2013, P59 (2013). https://doi.org/10.1186/1687-9856-2013-S1-P59
- Growth Hormone
- Growth Velocity
- Growth Hormone Deficiency
- Human Growth Hormone
- Growth Hormone Therapy